annual D&A:
$57.20M+$15.43M(+36.93%)Summary
- As of today (July 1, 2025), AMPH annual depreciation & amortization is $57.20 million, with the most recent change of +$15.43 million (+36.93%) on December 31, 2024.
- During the last 3 years, AMPH annual D&A has risen by +$30.67 million (+115.60%).
- AMPH annual D&A is now at all-time high.
Performance
AMPH Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$15.21M+$543.00K(+3.70%)Summary
- As of today (July 1, 2025), AMPH quarterly depreciation & amortization is $15.21 million, with the most recent change of +$543.00 thousand (+3.70%) on March 31, 2025.
- Over the past year, AMPH quarterly D&A has increased by +$1.24 million (+8.91%).
- AMPH quarterly D&A is now at all-time high.
Performance
AMPH quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$58.45M+$1.24M(+2.17%)Summary
- As of today (July 1, 2025), AMPH TTM depreciation & amortization is $58.45 million, with the most recent change of +$1.24 million (+2.17%) on March 31, 2025.
- Over the past year, AMPH TTM D&A has increased by +$10.11 million (+20.90%).
- AMPH TTM D&A is now at all-time high.
Performance
AMPH TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AMPH Depreciation and amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +36.9% | +8.9% | +20.9% |
3 y3 years | +115.6% | +123.8% | +120.5% |
5 y5 years | +170.8% | +161.2% | +158.2% |
AMPH Depreciation and amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +115.6% | at high | +122.7% | at high | +120.8% |
5 y | 5-year | at high | +170.8% | at high | +157.0% | at high | +158.2% |
alltime | all time | at high | +413.1% | at high | +400.4% | at high | +1823.3% |
AMPH Depreciation and amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $15.21M(+3.7%) | $58.45M(+2.2%) |
Dec 2024 | $57.20M(+36.9%) | $14.66M(+1.6%) | $57.20M(+1.6%) |
Sep 2024 | - | $14.43M(+2.0%) | $56.33M(+1.6%) |
Jun 2024 | - | $14.14M(+1.3%) | $55.47M(+14.7%) |
Mar 2024 | - | $13.96M(+1.3%) | $48.34M(+15.7%) |
Dec 2023 | $41.78M(+47.8%) | $13.79M(+1.6%) | $41.78M(+18.3%) |
Sep 2023 | - | $13.57M(+93.3%) | $35.31M(+21.5%) |
Jun 2023 | - | $7.02M(-5.1%) | $29.07M(+0.7%) |
Mar 2023 | - | $7.40M(+1.0%) | $28.88M(+2.1%) |
Dec 2022 | $28.27M(+6.6%) | $7.33M(+0.0%) | $28.27M(+3.6%) |
Sep 2022 | - | $7.33M(+7.3%) | $27.28M(+3.1%) |
Jun 2022 | - | $6.83M(+0.5%) | $26.47M(-0.1%) |
Mar 2022 | - | $6.79M(+7.3%) | $26.50M(-0.1%) |
Dec 2021 | $26.53M(+5.4%) | $6.33M(-2.7%) | $26.53M(-1.6%) |
Sep 2021 | - | $6.51M(-5.2%) | $26.97M(-0.6%) |
Jun 2021 | - | $6.87M(+0.6%) | $27.13M(+3.6%) |
Mar 2021 | - | $6.83M(+0.8%) | $26.18M(+4.0%) |
Dec 2020 | $25.18M(+19.2%) | $6.77M(+1.5%) | $25.18M(+4.7%) |
Sep 2020 | - | $6.67M(+12.7%) | $24.04M(+6.2%) |
Jun 2020 | - | $5.92M(+1.6%) | $22.63M(+3.8%) |
Mar 2020 | - | $5.82M(+3.4%) | $21.81M(+3.3%) |
Dec 2019 | $21.12M(+27.9%) | $5.63M(+6.9%) | $21.12M(+6.3%) |
Sep 2019 | - | $5.26M(+3.3%) | $19.87M(+5.8%) |
Jun 2019 | - | $5.09M(-0.7%) | $18.78M(+5.2%) |
Mar 2019 | - | $5.13M(+17.2%) | $17.86M(+8.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2018 | $16.52M(+4.5%) | $4.38M(+5.0%) | $16.52M(+2.3%) |
Sep 2018 | - | $4.17M(-0.1%) | $16.14M(+0.2%) |
Jun 2018 | - | $4.17M(+10.2%) | $16.11M(+2.1%) |
Mar 2018 | - | $3.79M(-5.3%) | $15.78M(-0.2%) |
Dec 2017 | $15.81M(+7.7%) | $4.00M(-3.4%) | $15.81M(+0.5%) |
Sep 2017 | - | $4.15M(+8.0%) | $15.72M(+2.8%) |
Jun 2017 | - | $3.84M(+0.5%) | $15.29M(+1.5%) |
Mar 2017 | - | $3.82M(-2.5%) | $15.07M(+2.7%) |
Dec 2016 | $14.68M(+10.8%) | $3.92M(+5.5%) | $14.68M(+4.6%) |
Sep 2016 | - | $3.71M(+2.7%) | $14.04M(+2.6%) |
Jun 2016 | - | $3.62M(+5.5%) | $13.69M(+1.9%) |
Mar 2016 | - | $3.43M(+4.6%) | $13.43M(+1.3%) |
Dec 2015 | $13.25M(-8.3%) | $3.28M(-2.5%) | $13.25M(-3.6%) |
Sep 2015 | - | $3.36M(+0.1%) | $13.75M(-2.3%) |
Jun 2015 | - | $3.36M(+3.3%) | $14.07M(-1.5%) |
Mar 2015 | - | $3.25M(-13.9%) | $14.29M(-1.1%) |
Dec 2014 | $14.45M(+10.5%) | $3.78M(+2.6%) | $14.45M(+2.2%) |
Sep 2014 | - | $3.68M(+2.9%) | $14.13M(+3.0%) |
Jun 2014 | - | $3.58M(+4.7%) | $13.72M(+2.0%) |
Mar 2014 | - | $3.42M(-1.3%) | $13.45M(+2.9%) |
Dec 2013 | $13.08M(+13.8%) | $3.46M(+5.8%) | $13.08M(+36.0%) |
Sep 2013 | - | $3.27M(-1.1%) | $9.62M(+51.5%) |
Jun 2013 | - | $3.31M(+8.9%) | $6.35M(+108.9%) |
Mar 2013 | - | $3.04M | $3.04M |
Dec 2012 | $11.50M(+3.1%) | - | - |
Dec 2011 | $11.15M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual D&A year-on-year change?
- What is Amphastar Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly D&A year-on-year change?
- What is Amphastar Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM D&A year-on-year change?
What is Amphastar Pharmaceuticals annual depreciation & amortization?
The current annual D&A of AMPH is $57.20M
What is the all time high annual D&A for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual depreciation & amortization is $57.20M
What is Amphastar Pharmaceuticals annual D&A year-on-year change?
Over the past year, AMPH annual depreciation & amortization has changed by +$15.43M (+36.93%)
What is Amphastar Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of AMPH is $15.21M
What is the all time high quarterly D&A for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly depreciation & amortization is $15.21M
What is Amphastar Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, AMPH quarterly depreciation & amortization has changed by +$1.24M (+8.91%)
What is Amphastar Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of AMPH is $58.45M
What is the all time high TTM D&A for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM depreciation & amortization is $58.45M
What is Amphastar Pharmaceuticals TTM D&A year-on-year change?
Over the past year, AMPH TTM depreciation & amortization has changed by +$10.11M (+20.90%)